Default company panoramic image


Isentio is a software as a service that can identify pathogens more accurately, much faster and at a lower cost than current methods through DNA sequencing.

  • Stage $500K in TTM Revenue
  • Industry Biotechnology
  • Location Sunnyvale, CA, USA
  • Currency USD
  • Founded 2009
  • Employees 5
  • Website

Company Summary

RipSeq, our software-as-a-service for clinical laboratories, is used to rapidly diagnose infections from DNA sequencing data by solving the bioinformatics problem of DNA sequence ID. It allows hospitals to significantly cut costs, improve mortality, and improve their workflow. RipSeq is currently used (bacterial, fungal, and soon viruses) in 60 major laboratory customers around the world (including Stanford, Mayo, ARUP, CDC and others).


  • Default avatar
    Oystein Saebo

    Øystein F. Sæbø, Chief Technical Officer, has 20 years of algorithm design and development experience with Microsoft, Motorola, Grant Thornton, Infogain, and Webstep. He developed Isentio's algorithms, cloud solutions, and web ­server deployment through server-­side parallel processing, and is considered by many to be a leading authority in his line of work. He holds a BA CS from South Dakota SM&T with graduate work at Cal Poly

  • Default avatar
    May Roen

    May Kristen Røen, COO, is experienced at scaling early-­stage companies. She has served on the boards of 10 companies and non-­profits, and has an international finance and business development background with multiple European and US startups. May earned an Executive MBA from the Norwegian School of Economics and Business Administration and an engineering degree from the University of Adger.

  • Default avatar
    Bjarte Karlsen

    Bjarte Karlsen, Chief Product Officer, has a broad background as a Senior Consultant managing diverse complex projects, a solid record of building lasting customer relationships across varied markets including medical microbiology, and an extensive network within diagnostic labs in Europe and North America. He holds a BA CS from Texas Lutheran College and a Candidatus Magisterii in Informatics from the University of Bergen, Norway.

  • Default avatar
    Oyvind Kommendal

    Dr. Øyvind Kommedal MD, PhD, Chief Medical Officer, is an acknowledged industry expert. As a MD in the Department of Microbiology and Immunology at Haukeland University Hospital, he has over 10 years of experience in diagnostics and research and leads an advanced brain abscess study using Next Generation Sequencing ("NGS") combined with RipSeq. He has authored numerous articles including many about RipSeq in over 10 scientific publications such a

  • Neil is a serial entrepreneur and has sold two of his own companies and 12 years of executive experience including sales, marketing, engineering, and finance. He previously worked at the Stanford Genome Technology Center sequencing pathogens and helping develop new genomic technologies. He has also been a healthcare management consultant and investment banker. Neil holds a BS in Bioengineering from UC San Diego.


  • Default avatar
    Frank Vargas
    Counsel to Isentio
    Default avatar
    Sveinung Hole
    Venture Capital
  • Default avatar
    Camilla Huse Bondesson
    EU Marketing